![Kåre Engkilde](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kåre Engkilde is a member of the Danish Society of Immunology and the Danish Society of Flow Cytometry.
He was the Chief Executive Officer of Amniotics AB from 2019 to 2022.
He has a graduate degree from the Technical University of Denmark and a doctorate degree from the University of Copenhagen.
His current job(s) include being a member of the Danish Society of Immunology and the Danish Society of Flow Cytometry.
| Companies | Position | Start |
|---|---|---|
Danish Society of Immunology | Corporate Officer/Principal | - |
Danish Society of Flow Cytometry | Corporate Officer/Principal | - |
| Companies | Position | End |
|---|---|---|
| AMNIOTICS AB | Chief Executive Officer | 30/08/2022 |
Active
Inactive
Listed companies
Private companies
| Private companies | 5 |
|---|---|
Technical University of Denmark
 Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Danish Society of Immunology | |
Amniotics AB
 Amniotics AB BiotechnologyHealth Technology Develops stem cell-based therapeutics for the treatment of human diseases | Health Technology |
Danish Society of Flow Cytometry |
Select your edition
All financial news and data tailored to specific country editions
